Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | EYA2 | O00167 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | ACE | P12821 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | DRD1 | P21728 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7506238 | 0.96 | HSD17B10 (0.40) | HSD17B10P2RY6OPRD1TDP1EYA2 | |
| SCHEMBL9429585 | 0.86 | HSD17B10 (0.39) | HSD17B10P2RY6OPRD1TDP1EYA2 | |
| SCHEMBL6757638 | 0.83 | HSD17B10 (0.39) | HSD17B10P2RY6OPRD1TDP1EYA2 | |
| SCHEMBL6550277 | 0.83 | HSD17B10 (0.39) | HSD17B10P2RY6OPRD1TDP1EYA2 | |
| SCHEMBL141450 | 0.83 | HSD17B10 (0.39) | HSD17B10P2RY6OPRD1TDP1EYA2 | |
| Isothiocyanate SCHEMBL28348502 | 0.81 | CYP1A2 (0.37) | TDP1EYA2APPACEKDM4E | |
| SCHEMBL7598191 | 0.81 | SLC7A5 (0.44) | TDP1EYA2APPACEKDM4E | |
| SCHEMBL7596061 | 0.81 | CYP1A2 (0.43) | TDP1EYA2APPACEKDM4E | |
| SCHEMBL29588115 | 0.81 | CYP1A2 (0.43) | TDP1EYA2APPACEKDM4E | |
| SCHEMBL8193027 | 0.81 | HSD17B10 (0.41) | HSD17B10P2RY6OPRD1TDP1EYA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6455025-B1 | POLYSACCHARIDE-SOMATOSTATIN ANALOGS; SOMATOSTATIN IS DIRECTLY OR INDIRECTLY COUPLED FROM A TERMINAL N-AMINO GROUP OF THE SOMATOSTATIN ANALOG TO A POLYSACCHARIDE; EFFECTIVE NEGATIVE CHARGE; DIAGNOSING AND TREATING CANCERS; RADIOLABELED | MAP MEDICAL TECHNOLOGIES OY (FI) | 2002-09-24 | — | — | US | claimed |
| EP-0951478-A1 | POLYSACCHARIDE-PEPTIDE DERIVATIVES | Map Medical Technologies Oy (FI) | 1999-10-27 | — | — | EP | claimed |
| WO-1998028336-A1 | POLYSACCHARIDE-PEPTIDE DERIVATIVES | MAP MEDICAL TECHNOLOGIES OY (FI) | 1998-07-02 | — | — | WO | claimed |
| EP-1592476-A1 | METHODS FOR THE PURIFICATION OF STABLE RADIOIODINE CONJUGATES | Immunomedics, Inc. (US) | 2005-11-09 | — | — | EP | disclosed |
| WO-2004071571-A1 | METHODS FOR THE PURIFICATION OF STABLE RADIOIODINE CONJUGATES | IMMUNOMEDICS, INC. (US) | 2004-08-26 | — | — | WO | disclosed |
| US-6455025-B1 | POLYSACCHARIDE-SOMATOSTATIN ANALOGS; SOMATOSTATIN IS DIRECTLY OR INDIRECTLY COUPLED FROM A TERMINAL N-AMINO GROUP OF THE SOMATOSTATIN ANALOG TO A POLYSACCHARIDE; EFFECTIVE NEGATIVE CHARGE; DIAGNOSING AND TREATING CANCERS; RADIOLABELED | MAP MEDICAL TECHNOLOGIES OY (FI) | 2002-09-24 | — | — | US | disclosed |
| EP-0835263-B9 | SOMATOSTATIN PEPTIDES | NOVARTIS AG (CH) | 2002-07-24 | — | — | EP | disclosed |
| EP-0835263-B1 | SOMATOSTATIN PEPTIDES | NOVARTIS AG (CH) | 2001-12-05 | — | — | EP | disclosed |
| US-6225284-B1 | Somatostatin peptides | NOVARTIS AG (CH) | 2001-05-01 | — | — | US | disclosed |
| US-5776894-A | Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors | NOVARTIS AG (CH) | 1998-07-07 | — | — | US | disclosed |
| US-5753627-A | Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis | NOVARTIS AG (CH) | 1998-05-19 | — | — | US | disclosed |
| EP-0835263-A2 | SOMATOSTATIN PEPTIDES | Novartis AG (CH) | 1998-04-15 | — | — | EP | disclosed |
| WO-1997001579-A2 | SOMATOSTATIN PEPTIDES | NOVARTIS AG (CH) | 1997-01-16 | — | — | WO | disclosed |
| EP-0741747-A1 | INHIBITORS OF SERINE PROTEASES, BEARING A CHELATING GROUP | Novartis AG (CH) | 1996-11-13 | — | — | EP | disclosed |
| WO-1995020603-A1 | INHIBITORS OF SERINE PROTEASES, BEARING A CHELATING GROUP | SANDOZ LTD. (CH) | 1995-08-03 | — | — | WO | disclosed |
| US-5334729-A | Derivatives of 1,2-diaminocyclohexanetetraacetic acid | ASSOCIATED UNIVERSITIES, INC. (US) | 1994-08-02 | — | — | US | disclosed |
| WO-1990006949-A2 | PEPTIDE DERIVATIVES | SANDOZ AG (CH) | 1990-06-28 | — | — | WO | disclosed |